Strides Pharma hits 52-week high on reporting turnaround Q1 performance

Strides Pharma Science added 2.46% to Rs 1,053.75 after the company reported a consolidated net profit of Rs 70.20 crore in Q1 FY25 as against a net loss of Rs 7.11 crore posted in Q1 FY24.